| Financial Year |
March 31 2023 |
| Monetary Funds |
453,168,399.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
150,125,304.11 |
| Advances to Suppliers |
3,899,026.13 |
| Other Receivables |
9,134,766.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
89,387,654.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
25,809,727.85 |
| Other Current Assets |
28,618,949.74 |
| Total Current Assets |
760,143,828.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
15,649,726.31 |
| Long-term Equity Investment |
70,223,247.62 |
| Investment Properties |
-- |
| Fixed Assetes |
247,274,236.16 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,547,629.13 |
| R&D expenses |
10,225,581.84 |
| Goodwill |
25,214,575.14 |
| Long-Term Deferred and Prepaid Expenses |
1,879,306.50 |
| Deferred Income Tax Assets |
43,074,992.55 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
472,378,692.41 |
| Total Assets |
1,232,522,520.80 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
4,000,000.00 |
| Notes Payable |
23,439,181.00 |
| Accounts Payable |
69,467,297.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,264,272.54 |
| Taxes Payable |
11,295,082.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,028,484.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,437,342.34 |
| Other Current Liabilities |
2,473,434.74 |
| Sub-Total of Current Liabilities |
164,510,193.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
602,176.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,694,659.49 |
| Total Liabilities |
167,204,852.82 |
| Paid-In Capital(Or Share Stock) |
399,514,567.00 |
| Capital Surplus |
18,479,058.08 |
| Surplus Reserve |
102,055,727.09 |
| LESS:Treasury Stock |
124,393,351.30 |
| Undistributed Profits |
641,920,358.41 |
| Minority Stockholder's Interest |
27,055,736.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,038,261,931.05 |
| Owner's Equity（Stockholder's Equity） |
1,065,317,667.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,232,522,520.80 |
